Boehringer Ingelheims SPEVIGO spesolimab wins 2023 Prix Galien USA Best OrphanRare Diseases Solution Award

Boehringer Ingelheim today announced that SPEVIGO spesolimab has been recognized as Best OrphanRare Diseases Solution of 2023 by the Galien Foundation.

Related Keywords

Germany ,New York ,United States ,Prix Galien ,Boehringer Ingelheim ,Carinne Brouillon ,Bruno Cohen ,Michel Pairet ,Galien Foundation ,Animal Health ,European Medicine Agency ,Prix Galien Foundation ,Drug Administration ,Rare Diseases Solution ,Prix Galien United States Award ,Managing Directors ,Human Pharma ,Corporate Headquarters ,Media Contact ,Boehringer Ingelheim Spevigo 2023 Prix Galien Usa Best Orphanrare Diseases Solution Foundation Us Food And Drug Administration Michel Pairet Carinne Brouillon Gpp Bruno Cohen Effisayil 2 Trial ,